The Food and Drug Administration approved its Optune Pax product, which delivers tumor treating fields, for certain ...

Japan-based cell therapy company Innovacell is planning to end a drought of biotech IPOs on the Tokyo stock exchange next week, the business’ CEO has confirmed. | Japan-based cell therapy company ...

Wall Street analysts are placing aggressive bets on four clinical-stage biotech companies, with consensus price targets implying gains of up to 384%. These pre-revenue or early-revenue firms carry ...

There's a growth stock that has skyrocketed more than Google parent Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) and Nvidia ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI age. Undoubtedly, it’s no mystery as to why many wish to be underweight in ...

Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her position in this stock, and it’s one of her top holdings. 10 stocks we like ...

The stake reduction represents a complete exit from Nuvalent, removing an allocation that was previously 13.8% of the fund’s reportable AUM in the prior quarter. Nuvalent is no longer in the portfolio ...

Krystal Biotech is rated a buy after a strong Vyjuvek launch, but the current valuation reflects premium margins and aggressive global expansion projections. Vyjuvek's US sales growth has plateaued, ...

Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...